Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Acta Neurologica Scandinavica
|
December 2, 2021
Elevated norepinephrine may interact with alpha-synuclein to promote Parkinson's disease and DLB
Paul J Fitzgerald
Neuroscience and Biobehavioral Reviews
|
July 8, 2009
Neuromodulating mice and men: Are there functional species differences in neurotransmitter concentration?
Paul J Fitzgerald
Medical Hypotheses
|
April 13, 2013
Black bile: are elevated monoamines an etiological factor in some cases of major depression?
Paul J Fitzgerald
Medical Hypotheses
|
June 1, 2012
Whose side are you on: does serotonin preferentially activate the right hemisphere and norepinephrine the left?
Paul J Fitzgerald
Frontiers in Pharmacology
|
November 24, 2025
Glucose may be biotransformed and then react with alcohol, fats, endocannabinoids, or various amino acids to form dopamine or norepinephrine <i>in vivo</i>
Paul J Fitzgerald
Pharmacology, Biochemistry, and Behavior
|
March 18, 2026
Loneliness, serotonin, and medial prefrontal cortex: some empirical and theoretical considerations
Paul J Fitzgerald
Current Alzheimer Research
|
July 15, 2010
Is elevated norepinephrine an etiological factor in some cases of Alzheimer's disease?
Paul J Fitzgerald
Substance Abuse : Research and Treatment
|
October 24, 2013
Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine
Paul J Fitzgerald
Medical Hypotheses
|
February 16, 2013
Elevated norepinephrine may be an etiological factor in a wide range of diseases: age-related macular degeneration, systemic lupus erythematosus, atrial fibrillation, metabolic syndrome
Paul J Fitzgerald
Clinical Neurology and Neurosurgery
|
May 30, 2021
Diurnal build-up of norepinephrine may underlie sundowning in dementia
Paul J Fitzgerald
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Acta Neurologica Scandinavica
|
December 2, 2021
Elevated norepinephrine may interact with alpha-synuclein to promote Parkinson's disease and DLB
Paul J Fitzgerald
Neuroscience and Biobehavioral Reviews
|
July 8, 2009
Neuromodulating mice and men: Are there functional species differences in neurotransmitter concentration?
Paul J Fitzgerald
Medical Hypotheses
|
April 13, 2013
Black bile: are elevated monoamines an etiological factor in some cases of major depression?
Paul J Fitzgerald
Medical Hypotheses
|
June 1, 2012
Whose side are you on: does serotonin preferentially activate the right hemisphere and norepinephrine the left?
Paul J Fitzgerald
Frontiers in Pharmacology
|
November 24, 2025
Glucose may be biotransformed and then react with alcohol, fats, endocannabinoids, or various amino acids to form dopamine or norepinephrine <i>in vivo</i>
Paul J Fitzgerald
Pharmacology, Biochemistry, and Behavior
|
March 18, 2026
Loneliness, serotonin, and medial prefrontal cortex: some empirical and theoretical considerations
Paul J Fitzgerald
Current Alzheimer Research
|
July 15, 2010
Is elevated norepinephrine an etiological factor in some cases of Alzheimer's disease?
Paul J Fitzgerald
Substance Abuse : Research and Treatment
|
October 24, 2013
Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine
Paul J Fitzgerald
Medical Hypotheses
|
February 16, 2013
Elevated norepinephrine may be an etiological factor in a wide range of diseases: age-related macular degeneration, systemic lupus erythematosus, atrial fibrillation, metabolic syndrome
Paul J Fitzgerald
Clinical Neurology and Neurosurgery
|
May 30, 2021
Diurnal build-up of norepinephrine may underlie sundowning in dementia
Paul J Fitzgerald
Page
of 7